Cas:887572-60-3 6-methoxy-1H-benzimidazole-2-carboxylic acid manufacturer & supplier

We serve Chemical Name:6-methoxy-1H-benzimidazole-2-carboxylic acid CAS:887572-60-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6-methoxy-1H-benzimidazole-2-carboxylic acid

Chemical Name:6-methoxy-1H-benzimidazole-2-carboxylic acid
CAS.NO:887572-60-3
Synonyms:5-methoxy-1H-benzimidazole-2-carboxylic acid;5-METHOXY-1H-BENZOIMIDAZOLE-2-CARBOXYLIC ACID
Molecular Formula:C9H8N2O3
Molecular Weight:192.17100
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:468.8ºC at 760 mmHg
Density:1.46g/cm3
Index of Refraction:1.689
PSA:75.21000
Exact Mass:192.05300
LogP:1.26970

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-methoxy-1H-benzimidazole-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-METHOXY-1H-BENZOIMIDAZOLE-2-CARBOXYLIC ACID physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-METHOXY-1H-BENZOIMIDAZOLE-2-CARBOXYLIC ACID Use and application,5-METHOXY-1H-BENZOIMIDAZOLE-2-CARBOXYLIC ACID technical grade,usp/ep/jp grade.


Related News: I look forward to working alongside such an ambitious team who are passionate about using cutting-edge technology to solve the health issues of the future and meet the needs of pharma and biotech companies across the globe.” 5-(3-Methylamino-propyl)-5,7-dihydro-dibenzo[d,f][1,3]diazepin-6-one manufacturers The incredible selectivity of enzyme catalysts consequently simplifies workflows by generating fewer by-products and reducing impurities to markedly decrease the total number of synthetic steps required. N-[6-(4-Hydroxy-phenyl)-6-oxo-hexyl]-benzamide suppliers The incredible selectivity of enzyme catalysts consequently simplifies workflows by generating fewer by-products and reducing impurities to markedly decrease the total number of synthetic steps required. 2-iodobut-2-en-1-ol vendor & factory “From the new company, we’ll be able to provide customers with invaluable access to high-quality sterile fill and finish capacity, which is in huge demand globally,” Recipharm CEO Marc Funk said in a release. ,Bluebird also earned an approval Wednesday in Europe for its gene therapy Lenti-D for children with early cerebral adrenoleukodystrophy and an ABCD1 genetic mutation without a matched sibling donor.